- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02094196
The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders (LeADP5)
The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders (LeAD P5)
The aim of this project is to assess reward- based learning behavior and its association with alterations in dopaminergic and glutamatergic transmission in detoxified alcohol-dependent patients and matched controls.
The investigators will explore how these alterations interact with clinical and psychosocial factors which can modify the relapse risk and learning deficits.
Patients will be detoxified in an inpatient setting. Clinical assessments, behavioral paradigms of learning and brain imaging will be carried out within at least 4 half- lives after any psychotropic medication.
The investigators will implement and apply functional imaging paradigms assessing Pavlovian-to-instrumental transfer and reversal learning tasks and associate model parameters of learning with alcohol craving, intake and prospective relapse risk.
In this project, the impact of the dopamine x glutamate interaction on learning deficits and consecutive relapse probability is targeted with [18F]fallypride PET and the measurement of absolute concentrations of glutamate with magnetic resonance spectroscopy (MRS).
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Alcohol consumption despite negative consequences may rely on impaired flexibility in adapting the behavior to environmental changes, i.e. learning in response to reward contingencies. This learning deficit is of clinical relevance particularly during therapy and for the psychosocial outcome.
The reduced availability of central dopamine D2-receptors in detoxified alcohol dependent patients observed in PET investigations and their hypothetical effects on reward-related learning are in line with evidence for learning deficits in hypodopaminergic states, particularly for avoidance learning in non-dependent samples. Growing evidence indicates that the learning-related striatal dopamine signals are modulated by higher executive functions involving, e.g., the prefrontal cortex.
Here, broad glutamatergic outputs of the prefrontal cortex are crucial for subcortical learning mechanisms and match with recent models of interactive dopamine-glutamate dysfunctions and models of neurotrophic signaling in alcohol dependence.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Berlin, Tyskland, 10117
- Charité - Universitätsmedizin Berlin
-
Berlin, Tyskland, 10115
- Charité Berlin, Division of Neuroimaging
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Alcohol dependence according to DSM-IV
- Minimum of 72 hours of abstinence, maximum of 21 days of abstinence
- Minimum of three years of alcohol dependence
- Low severity of withdrawal symptoms
- Ability to provide fully informed consent and to use self- rating scales
Exclusion Criteria:
- Lifetime history of DSM- IV bipolar or psychotic disorder
- Current threshold DSM-IV diagnosis of any following disorders: current major - depressive disorder, generalized anxiety disorder, PTSD, borderline personality disorder or obsessive- compulsive disorder
- History of substance dependence other than alcohol or nicotine dependence
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
---|---|
Controls, highrisk for AD
Community-based ad-hoc participants, high risk for alcohol dependence, matched to inpatients by sociodemographics
|
|
Controls, low risk for AD
Community-based ad-hoc participants, low risk for alcohol dependence, matched to inpatients by sociodemographics
|
|
Alcohol detoxification
Inpatients with alcohol dependence from local psychiatric hospital wards (18-65 years old)
|
Detoxified alcohol- dependent patients in an inpatient setting
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Striatal D2-receptor availability (PET) and prefrontal glutamate concentration (MRS)
Tidsramme: first assessment time point (alc. dependent pat. up to 21 days after detoxification)
|
reduction in striatal D2-receptor availability and a increase in prefrontal glutamate concentration in alcohol-dependent patients compared to healthy controls
|
first assessment time point (alc. dependent pat. up to 21 days after detoxification)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
behavioral data in reward-habit-learning paradigms
Tidsramme: first assessment time point (alc. dependent pat. up to 21 days after detoxification)
|
Reduced learning speed and PIT withdrawal score in the probabilistic reversal learning task
|
first assessment time point (alc. dependent pat. up to 21 days after detoxification)
|
Treatment response
Tidsramme: 12-month follow-up period beginning after first assessment timepoint
|
test the predictive effects of striatal D2-receptor availability and prefrontal glutamate availability for treatment outcome (relapse vs abstinence) in alcohol-dependent patients
|
12-month follow-up period beginning after first assessment timepoint
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
striatal-prefrontal connectivity (fMRI)
Tidsramme: first assessment time point (alc. dependent pat. up to 21 days after detoxification)
|
striatal-prefrontal connectivity (see other LeAD-projects) in the probabilistic reversal learning task
|
first assessment time point (alc. dependent pat. up to 21 days after detoxification)
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Jürgen Gallinat, Prof MD, Charite University, Berlin, Germany
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- GA707/6-1
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Alcohol detoxification
-
Vanderbilt University Medical CenterAvsluttet
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Johns Hopkins... og andre samarbeidspartnereHar ikke rekruttert ennåHIV-forebygging | Usunn alkoholbrukVietnam
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Fullført
-
University of California, RiversideHar ikke rekruttert ennåAlkohol; Skadelig bruk | AlkoholbruksforstyrrelseForente stater
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Aktiv, ikke rekrutterendeAlkohol; Bruk, problemForente stater
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)FullførtAlkoholdrikking | Problem med å drikkeForente stater
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Johns Hopkins... og andre samarbeidspartnereHar ikke rekruttert ennåHIV-1-infeksjon | Usunn alkoholbrukVietnam
-
Abby BraitmanNational Institute on Alcohol Abuse and Alcoholism (NIAAA)FullførtStudent som drikker
-
University of Alabama at BirminghamRekrutteringHiv | AlkoholproblemForente stater
-
Johnson & Johnson Consumer Inc. (J&JCI)Fullført